GSK plc (GSK)
Pre-Market:
| Previous Close | 39.60 |
| Open | 39.39 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1400 |
| Day's Range | 39.15 - 39.50 |
| 52 Week Range | 33.33 - 43.84 |
| Volume | |
| Avg. Volume | 3,588,332 |
| Market Cap | 80.755B |
| Beta (5Y Monthly) | 0.27 |
| PE Ratio (TTM) | 13.18 |
| EPS (TTM) | 2.98 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.47 (3.74%) |
| Ex-Dividend Date | Feb 22, 2024 |
| 1y Target Est | 45.32 |
CNW GroupGSK Canada expands charitable partnerships to include support of environmental sustainability and STEM
GSK is proud to announce new charitable partnerships in STEM (science, technology, engineering and math) education for underrepresented communities and environmental sustainability. The company's newest philanthropic collaborations are an exciting opportunity to support our commitment to the health of our planet and the next generation of scientists in an equal and inclusive manner.
Insider Monkey10 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it’s one of the biggest trends on the stock market right now, then you can take a look at the […]
ZacksGSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.
